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Large vessels vasculitis and more speciﬁcally, Giant cell arteritis, is characterized by increased inﬂammatory markers, headaches
and altered clinical status. Diagnosis is conﬁrmed by biopsy of temporal arteries showing the presence of granuloma and vasculitis.
We hereby report the case of a patient presenting initially as pericarditis and revealing large vessel vasculitis using FDG-PET.
1.Introduction
In April 2009, a 63-year-old woman was admitted to our
hospital because of a frontal headache that occurred when
she woke up. She did not experience nausea or vomiting
and was temporarily relieved by acetaminophen. She also
complained of precordial chest pain developing, the same
morning. The thoracic pain was described as continuous,
nonconstrictive, not related to breathing, with no irradia-
tion, and which decreased when she laid down. Her past
medical history was marked by a COPD gold II condition,
a chronic left arm oedema of undetermined origin, and an
appendicectomy. Her current medications included an asso-
ciationofﬂuticasoneandsalmeterolaswellastiotropiumfor
the COPD. She had been smoking 100 cigarette pack-years,
had occasional alcohol consumption, and didnot have any
known allergy. She had been working as an employee for
an administrative district. The initial physical examination
revealed a satisfactory general condition and normal vital
signs. The only clinical abnormality was the presence of a
murmur on the left supraclavicular area.
The ﬁrst blood test showed an elevation of C-reactive
protein at 9.8mg/dL and a mild normocytic anemia at
11.1g/dL. The level of T troponin and CK-MB was normal.
The electrocardiogram showed normal sinus rhythm and
negative T waves of small amplitude in the second precordial
derivation. The arterial blood gases were normal as was
the cerebral computed tomography. A computed tomog-
raphy of the pulmonary artery did not reveal pulmonary
embolism but disclosed a circumferential pericardial eﬀu-
sion. A transthoracic echocardiogram conﬁrmed a 300mL
pericardial eﬀusion without hemodynamic repercussions.
The patient was managed as an outpatient and treated with
4 grams of aspirin each day for idiopathic pericarditis. After
twoweeksofthisregimen,theinﬂammatorysyndromefailed
to subside, and the controlled transthoracic echocardiogram
did not show any improvement of the pericardial eﬀusion.
During the course of the following days, the patient devel-
oped fatigue and was referred to the consultation of general
internal medicine. Suspecting giant cell arteritis, 18FDG-PET
was performed because the patient refused the temporal
artery biopsy. It revealed striking hypermetabolism of the
thoracic and abdominal aortic wall, highly suggestive of
large vessel vasculitis (Figure 1). 1mg/Kg/d of equivalent
prednisone was started. The symptoms were resolved over
a few days. The pericardial eﬀusion and the inﬂammatory
syndrome subsided. Six months after the beginning of
the treatment, the 18FDG-PET didnot show any hyperme-
tabolism in the aortic walls (Figure 1).
2. Discussion
This case highlights the importance of recognising peri-
carditis as a possible initial manifestation of giant cell2 ISRN Rheumatology
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Figure 1: (a) and (b): Coronal fused PET/CT (a) and sagittal fused PET/CT (b) through the thorax show increased FDG uptake of the
thoracic aortic wall. (c) and (d): Coronal fused PET/CT (c) and sagittal fused PET/CT (d) through the thorax show disappearance of FDG
uptake of the aortic wall after six months of treatment.
arteritis in patients over 50 years old [1]. It also emphasises
the promising role of FDG-PET as a minimally invasive
alternative procedure to temporal artery biopsy [2]. FDG-
PET can also be used in the followup of patients with giant
cellarteritisandseemstoidentifyasubpopulationofpatients
at risk of developing thoracic aortic dilatation [3]. In the
present case, the diagnosis of large vessel vasculitis (and
most probably giant cell arteritis) has been made based upon
clinical grounds, biological markers, and FDG-PET. In spite
of the fact that temporal artery biopsy is mandatory to
conﬁrm the diagnosis of giant cell arteritis, FDG-PET can be
a very useful tool in delineating the diagnostic process.
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